16 results
10-K
2023 FY
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
forth certain requirements as to the responsibilities, composition and independence of compensation committees. English law requires that we disclose … is engaged to render such services;
evaluating the independent auditor’s qualifications, performance and independence, and presenting its conclusions
8-K
EX-10.3
AUTL
Autolus Therapeutics plc
8 Feb 24
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
6:06am
Affiliates, (iii) information reasonably requested by the Company in connection with assessing eligibility, independence, and other criteria applicable
6-K
EX-1
AUTL
Autolus Therapeutics plc
1 Jul 22
Current report (foreign)
5:15pm
Code does not apply to us because our securities are listed solely on NASDAQ. For example, in order to conform to director independence standards … 31 December 2021
Independence
We are independent of the Group and Parent Company in accordance with the ethical requirements that are relevant to our
6-K
EX-1
AUTL
Autolus Therapeutics plc
30 Jun 21
Annual Report and Accounts
6:05am
because our securities are listed solely on NASDAQ. For example, in order to conform to director independence standards applicable in the United States
6-K
EX-1.1
sgswm
18 Sep 20
Autolus Therapeutics presents additional data on AUTO3 in DLBCL during the ESMO
7:12am
6-K
EX-1
zgltr
26 May 20
Current report (foreign)
4:31pm
6-K
EX-1
gy8 lqa91
15 Mar 19
Annual Report and Accounts
5:26pm
20-F
wpnvpmca5vghdinah
23 Nov 18
Annual report (foreign)
12:00am
424B4
c44bcm m6x3k
22 Jun 18
Prospectus supplement with pricing info
4:02pm
F-1/A
m3nnd
19 Jun 18
Registration statement (foreign) (amended)
8:05am
F-1/A
nnemwnkwxxpt7slxz88o
8 Jun 18
Registration statement (foreign) (amended)
6:25am
F-1/A
lswnpo70f4 zox
10 May 18
Registration statement (foreign) (amended)
5:19pm
F-1
wxgeagx
7 May 18
Registration statement (foreign)
4:45pm
- Prev
- 1
- Next